Clinical potential of brodalumab in the management of psoriasis: the evidence to date
Laura F Sandoval,1 Brooke Williams,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA; 2Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA; 3Department of Public Health Scie...
Guardado en:
Autores principales: | Sandoval LF, Williams B, Feldman SR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e460669aee4546c284912a052ce96d84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014) -
Self-management in patients with psoriasis
por: Pathak SN, et al.
Publicado: (2014) -
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
por: Machado Á, et al.
Publicado: (2018) -
Quality of life issues and measurement in patients with psoriasis
por: Tan X, et al.
Publicado: (2012) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021)